Source:http://linkedlifedata.com/resource/pubmed/id/18482917
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
Pt 3
|
pubmed:dateCreated |
2008-5-16
|
pubmed:abstractText |
Patent Blue V is an inert dye increasingly being used during cancer surgery to identify the sentinel lymph node. We recently discovered three cases with falsely elevated lipaemic indices on the Roche Modular, following intramammary injection of Patent Blue. This, and other potential interferences by Patent Blue, is examined in this study.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0004-5632
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
45
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
289-92
|
pubmed:meshHeading |
pubmed-meshheading:18482917-Blood Chemical Analysis,
pubmed-meshheading:18482917-Coloring Agents,
pubmed-meshheading:18482917-Hemolysis,
pubmed-meshheading:18482917-Humans,
pubmed-meshheading:18482917-Lymphatic Metastasis,
pubmed-meshheading:18482917-Reference Values,
pubmed-meshheading:18482917-Rosaniline Dyes
|
pubmed:year |
2008
|
pubmed:articleTitle |
Interference with serum indices measurement, but not chemical analysis, on the Roche Modular by Patent Blue V.
|
pubmed:affiliation |
Department of Clinical Biochemistry, Wythenshawe Hospital, Manchester, UK. denise.darby@nhs.net
|
pubmed:publicationType |
Journal Article
|